Skip to main content
Clinical Trials/NCT04422990
NCT04422990
Completed
Not Applicable

Clinical Evaluation of a Silicone Hydrogel Daily Wear Monthly Replacement Contact Lens

Alcon Research1 site in 1 country158 target enrollmentOctober 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Refractive Errors
Sponsor
Alcon Research
Enrollment
158
Locations
1
Primary Endpoint
Least Squares Mean Contact Lens Corrected Distance Visual Acuity (CLCDVA) at Week 1 Follow-Up
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this clinical study is to evaluate the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in a daily wear modality.

Detailed Description

Subjects will be expected to attend 4 office visits: Screening/Baseline/Dispense, Week 1 Follow-up, Month 1 Follow-up, and Month 3 Follow-up/Exit. The total expected duration of participation for each subject is approximately 3-4 months in this daily wear clinical study.

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
May 18, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Successful wear of spherical daily wear frequent replacement soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day;
  • Manifest cylinder equal to or less than 0.75 diopter (D) in each eye;
  • Best spectacle corrected visual acuity (using manifest refraction) of 20/20 or better in each eye;
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
  • Habitually wearing Biofinity lenses;
  • Monovision or multifocal contact lens wearers;
  • Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Least Squares Mean Contact Lens Corrected Distance Visual Acuity (CLCDVA) at Week 1 Follow-Up

Time Frame: Week 1 Follow-Up

Visual acuity (VA) was assessed for each eye individually with study lenses in place using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity.

Secondary Outcomes

  • Percentage of Subjects Achieving CLCDVA 20/20 or Better in Each Eye at Week 1 Follow-Up(Week 1 Follow-Up)

Study Sites (1)

Loading locations...

Similar Trials